Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 13, 2015 17:00 ET | Source: Akorn, Inc.

Akorn Appoints Duane A. Portwood as Chief Financial Officer

LAKE FOREST, Ill., Oct. 13, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Duane A. Portwood, 49, will join Akorn as...
September 28, 2015 07:00 ET | Source: Akorn, Inc.

Akorn Launches Myorisan(TM) 30 mg Capsules

LAKE FOREST, Ill., Sept. 28, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched the recently-approved 30 mg strength...
September 21, 2015 07:00 ET | Source: Akorn, Inc.

Akorn Launches Doxercalciferol Injection

LAKE FOREST, Ill., Sept. 21, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched Doxercalciferol Injection Solution, 4...
September 17, 2015 07:00 ET | Source: Akorn, Inc.

Akorn Launches Two Additional Promethazine Syrup Formulations

LAKE FOREST, Ill., Sept. 17, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched Promethazine Hydrochloride and...
August 14, 2015 16:01 ET | Source: Akorn, Inc.

Akorn Receives NASDAQ Delinquency Notice

LAKE FOREST, Ill., Aug. 14, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX) today announced that, as expected, it has received a notice from the NASDAQ Staff stating that the Company is not in...
August 04, 2015 16:35 ET | Source: Akorn, Inc.

Akorn Appoints Randy Pollard as Interim Chief Financial Officer

LAKE FOREST, Ill., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX) today announced the appointment of Randall Pollard as Chief Accounting Officer and Interim Chief Financial Officer. Mr....
July 15, 2015 07:00 ET | Source: Akorn, Inc.

Akorn Announces Nasdaq's Acceptance of Its Plan to Regain Compliance

LAKE FOREST, Ill., July 15, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), today announced that the Nasdaq Stock Market has accepted the company's plan to regain compliance with Nasdaq Listing...
July 08, 2015 07:00 ET | Source: Akorn, Inc.

Akorn Launches Acetylcysteine Injection

LAKE FOREST, Ill., July 8, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched Acetylcysteine Injection 6 g/30 mL in 30...
May 18, 2015 07:00 ET | Source: Akorn, Inc.

Akorn Receives NASDAQ Delinquency Notice

LAKE FOREST, Ill., May 18, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX) today announced it has received a notice from NASDAQ stating the Company is not in compliance with Listing Rule 5250(c)(1)...
April 27, 2015 07:00 ET | Source: Akorn, Inc.

Akorn Announces Recent Executive Appointments

- New EVP Sales and Marketing to Oversee All Akorn Commercial Operations - - Newly Appointed Controller Strengthens Akorn's Finance Team - - New EVP Pharmaceutical Operations to Oversee Supply...